Optimizing Interventional Pharmacology for PCI in ACS: Applying the Evidence to Real-World Settings
Release Date: June 8, 2007 Expiration Date: June 8, 2008
Recorded during the Society for Cardiovascular Angiography and Interventions (SCAI) 30th Annual Scientific Sessions in Orlando, Florida, this highly dynamic, case-based symposium provides interventional cardiologists and other clinicians with detailed information and lively discussion on pharmacoinvasive therapies to improve the outcomes of patients undergoing PCI. The faculty will address patient management challenges presented by differing organizational protocols and discuss options for the interventional clinician. Using an innovative case-based approach, participants will consider the implications of various factors, including initial clinical presentation of ACS, the facility's capability to perform PCI, time delays from symptom onset to reperfusion, and the risk of adverse outcomes.
New Perspectives and Controversies in Cardiology: A CME-certified Webinar from the 2005 American Heart Association Satellite Symposium
Release Date: January 2006 Expiration Date: January 2007
Upon completion of this educational activity, the participant should be able to:
Discuss the use of beta blockers and angiotensin receptor blockers (ARBs) in patients with diabetes and the metabolic syndrome who are at high risk for the development of Stage A HF
Review the contribution of the metabolic syndrome to the occurrence of HF
Provide perspective on the role of beta blockers in an era of implantable cardioverter-defibrillator (ICD) implantation in patients with HF
Contrast the process of remodeling in men vs women with HF
Compare and contrast the American College of Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines for HF
New Guideline Goals: The Assessment of ARB Use in the Treatment of Heart Failure
Implications of New Data on the Updated ACC/AHA Guidelines
Release date: December 2005 Expiration date: December 2006
Upon completion of this activity, participants will be able to:
Discuss applications of the new American College of Cardiology (ACC)/American Heart Association (AHA) guidelines
Examine a stepwise approach to managing the HF patient
Detail how patients should be monitored to prevent complications related to complex pharmacotherapy regimens (eg, hyperkalemia)
Flash Player is required to view the webinar and is available as a free download by clicking here.
New Guideline Goals: The Assessment of ARB Use in the Treatment of Heart Failure
Chronic Heart Failure: The Scope of the Problem
Release date: December 2005 Expiration date: December 2006
Upon completion of this activity, participants will be able to:
Explain how chronic activation of the renin-angiotensin-aldosterone system (RAAS) can influence the progression of heart failure (HF)
Discuss the implications of recent clinical trials showing that some angiotensin receptor blockers (ARBs) can improve outcomes in patients with low or normal left ventricular ejection fraction (LVEF) HF
Discuss applications of the new American College of Cardiology (ACC)/American Heart Association (AHA) guidelines
Detail how patients should be monitored to prevent complications related to complex pharmacotherapy regimens (eg, hyperkalemia)
Flash Player is required to view the webinar and is available as a free download by clicking here.
New Guideline Goals: The Assessment of ARB Use in the Treatment of Heart Failure
Review of the Evidence from Recent Trials: Management of Chronic Heart Failure
Release date: December 2005 Expiration date: December 2006
Upon completion of this activity, participants will be able to:
Explain how chronic activation of the renin-angiotensin-aldosterone system (RAAS) can influence the progression of heart failure (HF)
Discuss the implications of recent clinical trials showing that some angiotensin receptor blockers (ARBs) can improve outcomes in patients with low or normal left ventricular ejection fraction (LVEF) HF
Examine a stepwise approach to managing the HF patient, including why and when to use ARBs
Flash Player is required to view the webinar and is available as a free download by clicking here.
